IDEX Corp has a consensus price target of $243.92 based on the ratings of 14 analysts. The high is $277 issued by Citigroup on April 8, 2024. The low is $200 issued by Mizuho on April 28, 2023. The 3 most-recent analyst ratings were released by Stifel, Baird, and Oppenheimer on July 18, 2024, April 25, 2024, and April 18, 2024, respectively. With an average price target of $248 between Stifel, Baird, and Oppenheimer, there's an implied 20.85% upside for IDEX Corp from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/18/2024 | Buy Now | 15% | Stifel | Nathan Jones | $265 → $236 | Maintains | Buy | Get Alert |
04/25/2024 | Buy Now | 24.74% | Baird | Michael Halloran | $260 → $256 | Maintains | Outperform | Get Alert |
04/18/2024 | Buy Now | 22.8% | Oppenheimer | Bryan Blair | $245 → $252 | Maintains | Outperform | Get Alert |
04/08/2024 | Buy Now | 34.98% | Citigroup | Vladimir Bystricky | $254 → $277 | Maintains | Buy | Get Alert |
03/21/2024 | Buy Now | 24.26% | RBC Capital | Deane Dray | → $255 | Reiterates | Outperform → Outperform | Get Alert |
02/08/2024 | Buy Now | 24.26% | RBC Capital | Deane Dray | $234 → $255 | Maintains | Outperform | Get Alert |
02/08/2024 | Buy Now | 29.13% | Stifel | Nathan Jones | $215 → $265 | Upgrade | Hold → Buy | Get Alert |
01/23/2024 | Buy Now | 4.77% | Stifel | Nathan Jones | $214 → $215 | Maintains | Hold | Get Alert |
12/19/2023 | Buy Now | 4.28% | Stifel | Nathan Jones | $213 → $214 | Maintains | Hold | Get Alert |
10/19/2023 | Buy Now | 19.38% | Oppenheimer | Bryan Blair | → $245 | Reiterates | Outperform → Outperform | Get Alert |
08/24/2023 | Buy Now | 21.82% | Argus Research | John Eade | $225 → $250 | Maintains | Buy | Get Alert |
07/31/2023 | Buy Now | 19.38% | Oppenheimer | Bryan Blair | → $245 | Reiterates | Outperform → Outperform | Get Alert |
07/28/2023 | Buy Now | 24.26% | Citigroup | Vladimir Bystricky | $243 → $255 | Maintains | Buy | Get Alert |
07/19/2023 | Buy Now | 7.2% | Stifel | Nathan Jones | $214 → $220 | Maintains | Hold | Get Alert |
05/22/2023 | Buy Now | 14.51% | TD Cowen | Joseph Giordano | $240 → $235 | Maintains | Outperform | Get Alert |
05/01/2023 | Buy Now | 19.38% | Oppenheimer | Bryan Blair | → $245 | Reiterates | → Outperform | Get Alert |
04/28/2023 | Buy Now | -2.54% | Mizuho | Brett Linzey | $227 → $200 | Maintains | Neutral | Get Alert |
04/28/2023 | Buy Now | 18.41% | RBC Capital | Deane Dray | $252 → $243 | Maintains | Outperform | Get Alert |
04/28/2023 | Buy Now | 18.41% | Citigroup | Vladimir Bystricky | $268 → $243 | Maintains | Buy | Get Alert |
04/28/2023 | Buy Now | 34% | Wells Fargo | Allison Poliniak | $280 → $275 | Maintains | Overweight | Get Alert |
04/28/2023 | Buy Now | 7.2% | Bernstein | Brendan Luecke | $225 → $220 | Maintains | Market Perform | Get Alert |
04/28/2023 | Buy Now | 12.07% | Baird | Michael Halloran | $255 → $230 | Maintains | Outperform | Get Alert |
04/24/2023 | Buy Now | 19.38% | Oppenheimer | Bryan Blair | $247 → $245 | Maintains | Outperform | Get Alert |
04/17/2023 | Buy Now | 19.87% | Stifel | Nathan Jones | $242 → $246 | Maintains | Hold | Get Alert |
02/02/2023 | Buy Now | 10.61% | Mizuho | Brett Linzey | $225 → $227 | Maintains | Neutral | Get Alert |
02/02/2023 | Buy Now | 20.36% | Oppenheimer | Bryan Blair | $245 → $247 | Maintains | Outperform | Get Alert |
02/02/2023 | Buy Now | 24.26% | Baird | Michael Halloran | $227 → $255 | Maintains | Outperform | Get Alert |
02/02/2023 | Buy Now | 30.59% | Citigroup | Vladimir Bystricky | $273 → $268 | Maintains | Buy | Get Alert |
01/26/2023 | Buy Now | 19.38% | Oppenheimer | Bryan Blair | $235 → $245 | Maintains | Outperform | Get Alert |
01/20/2023 | Buy Now | 17.92% | Stifel | Nathan Jones | $241 → $242 | Maintains | Hold | Get Alert |
01/18/2023 | Buy Now | 21.82% | Morgan Stanley | Connor Lynagh | $235 → $250 | Maintains | Overweight | Get Alert |
01/13/2023 | Buy Now | 9.64% | Mizuho | Brett Linzey | $208 → $225 | Maintains | Neutral | Get Alert |
12/09/2022 | Buy Now | 33.03% | Citigroup | Vladimir Bystricky | $228 → $273 | Maintains | Buy | Get Alert |
10/27/2022 | Buy Now | 1.35% | Mizuho | Brett Linzey | $205 → $208 | Maintains | Neutral | Get Alert |
10/27/2022 | Buy Now | 29.13% | Wells Fargo | Allison Poliniak Cusic | $260 → $265 | Maintains | Overweight | Get Alert |
10/27/2022 | Buy Now | 14.51% | Morgan Stanley | Connor Lynagh | $225 → $235 | Maintains | Overweight | Get Alert |
10/11/2022 | Buy Now | 2.82% | Stifel | Nathan Jones | $213 → $211 | Maintains | Hold | Get Alert |
08/17/2022 | Buy Now | 7.2% | Bernstein | Brendan Luecke | → $220 | Reinstates | → Market Perform | Get Alert |
08/01/2022 | Buy Now | -0.11% | Mizuho | Brett Linzey | $190 → $205 | Maintains | Neutral | Get Alert |
07/28/2022 | Buy Now | 6.71% | RBC Capital | Deane Dray | $216 → $219 | Maintains | Outperform | Get Alert |
07/19/2022 | Buy Now | -2.54% | Loop Capital | Scott Graham | $220 → $200 | Maintains | Hold | Get Alert |
07/18/2022 | Buy Now | -7.42% | Mizuho | Brett Linzey | $205 → $190 | Maintains | Neutral | Get Alert |
07/18/2022 | Buy Now | -8.39% | Stifel | Nathan Jones | $229 → $188 | Downgrade | Buy → Hold | Get Alert |
07/14/2022 | Buy Now | 4.77% | Oppenheimer | Bryan Blair | → $215 | Upgrade | Perform → Outperform | Get Alert |
06/09/2022 | Buy Now | 9.64% | Morgan Stanley | Connor Lynagh | $250 → $225 | Maintains | Overweight | Get Alert |
04/28/2022 | Buy Now | 15.97% | RBC Capital | Deane Dray | $234 → $238 | Maintains | Outperform | Get Alert |
04/28/2022 | Buy Now | 14.51% | Citigroup | Vladimir Bystricky | $232 → $235 | Maintains | Buy | Get Alert |
04/28/2022 | Buy Now | -0.11% | Mizuho | Brett Linzey | $233 → $205 | Maintains | Neutral | Get Alert |
04/18/2022 | Buy Now | 12.56% | Stifel | Nathan Jones | $244 → $231 | Maintains | Buy | Get Alert |
03/09/2022 | Buy Now | — | Cowen & Co. | Joseph Giordano | — | Upgrade | Market Perform → Outperform | Get Alert |
01/11/2022 | Buy Now | 12.07% | Bernstein | Brendan Luecke | → $230 | Initiates | → Market Perform | Get Alert |
12/17/2021 | Buy Now | 13.54% | Mizuho | Brett Linzey | — | Initiates | → Neutral | Get Alert |
10/28/2021 | Buy Now | 23.77% | RBC Capital | Deane Dray | — | Maintains | Outperform | Get Alert |
10/20/2021 | Buy Now | 19.87% | Citigroup | Vladimir Bystricky | — | Upgrade | Neutral → Buy | Get Alert |
The latest price target for IDEX (NYSE:IEX) was reported by Stifel on July 18, 2024. The analyst firm set a price target for $236.00 expecting IEX to rise to within 12 months (a possible 15.00% upside). 13 analyst firms have reported ratings in the last year.
The latest analyst rating for IDEX (NYSE:IEX) was provided by Stifel, and IDEX maintained their buy rating.
The last upgrade for IDEX Corp happened on February 8, 2024 when Stifel raised their price target to $265. Stifel previously had a hold for IDEX Corp.
The last downgrade for IDEX Corp happened on July 18, 2022 when Stifel changed their price target from $229 to $188 for IDEX Corp.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of IDEX, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for IDEX was filed on July 18, 2024 so you should expect the next rating to be made available sometime around July 18, 2025.
While ratings are subjective and will change, the latest IDEX (IEX) rating was a maintained with a price target of $265.00 to $236.00. The current price IDEX (IEX) is trading at is $205.22, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.